BIB icon

ProShares Ultra NASDAQ Biotechnology
BIB

Overview Fund Activity

24 hedge funds and large institutions have $6.47M invested in ProShares Ultra NASDAQ Biotechnology in 2024 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
24
Holders Change
+3
Holders Change %
+14.29%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
5
Closed
4
Calls
$764K
Puts
$972K
Net Calls
-$208K
Net Calls Change
-$24K

Top Buyers

1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
$954K
2
TRCT
Tower Research Capital (TRC)
New York
$731K
3
IMC Chicago
IMC Chicago
Illinois
$702K
4
Citadel Advisors
Citadel Advisors
Florida
$532K
5
Jane Street
Jane Street
New York
$262K

Top Sellers

1
TFA
Toth Financial Advisory
Virginia
$750K
2
TCBWMS
Texas Capital Bank Wealth Management Services
Texas
$0
3
JPMorgan Chase & Co
JPMorgan Chase & Co
New York
$0
4
CIC
Chase Investment Counsel
Virginia
$624K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
$3.14K
Name Holding Trade Value Shares
Change 		Shares
Change %
JPMorgan Chase & Co
26
JPMorgan Chase & Co
New York
– -$144K -2,500 Closed
TC
27
Truvestments Capital
Florida
– -$7.19K -125 Closed
Bank of America
28
Bank of America
North Carolina
– -$575 -10 Closed
1
2